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1  |  INTRODUCTION
Neuregulin-4 (NRG4) is one of the six identified members of 
the EGF-like neuregulin family, which are widely expressed 
pleiotropic growth factors related to epidermal growth factor 
that signal via the ErbB family of receptor tyrosine kinases, 
namely, ErbB1, ErbB2, ErbB3, and ErbB4 (Britsch,  2007; 
Mae & Nave,  2014). The neuregulins are extensively ex-
pressed in the nervous system and have numerous roles in 
the development and function of neurons and glia, including 
regulating the assembly of neural circuitry, myelination, neu-
rotransmission, and synaptic plasticity (Mei & Nave, 2014). 
Furthermore, Nrg1, Nrg2, Nrg3, Nrg6, ErbB3, and ErbB4 
have been identified as susceptibility genes for schizophre-
nia, depression, and bipolar disorder (Mei & Nave,  2014; 
Rico & Marin, 2011). In contrast to other neuregulins, initial 
reports suggested that NRG4 has no or negligible expression 
in adult brain (Harari et al., 1999; Rosell et al., 2014), which 
may explain the dearth of studies of the potential neural 
functions of NRG4. However, the recent demonstration that 
NRG4 is widely expressed in the developing brain facilitated 
the discovery that NRG4 is a key physiological regulator of 
cortical pyramidal and striatal medium spiny neuron den-
drite growth and elaboration during development (Paramo 
et al., 2018, 2019). NRG4 has also been shown to promote 
the growth of developing sympathetic axons and plays a key 
role in regulating the sympathetic innervation of adipose tis-
sue (Pellegrinelli et al., 2018).
Unlike other members of the neuregulin family, the in-
volvement of NRG4 in neural development and function 
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Abstract
Recent work has shown that neuregulin-4 (NRG4) is a physiological regulator of the 
growth of sympathetic axons and CNS dendrites in the developing nervous system. 
Here, we have investigated whether NRG4 plays a role in sensory axon growth and 
the establishment of cutaneous sensory innervation. Imaging early nerve fibers in 
the well-characterized cutaneous trigeminal territory, the brachial plexus, and tho-
rax revealed very marked and highly significant decreases in nerve fiber length and 
branching density in Nrg4−/− embryos compared with Nrg4+/+ littermates. NRG4 
promoted neurotrophin-independent sensory axon growth from correspondingly 
early trigeminal ganglion and DRG neurons in culture but not from enteroceptive 
nodose ganglion neurons. High levels of Nrg4 mRNA were detected in cutaneous 
tissues but not in sensory ganglia. Our findings suggest that NRG4 is an important 
target-derived factor that participates in the establishment of early cutaneous sensory 
innervation.
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has only been recently described. These emerging roles of 
NRG4 in the developing brain and peripheral nervous sys-
tem led us to investigate whether NRG4 plays any role in 
the development of another important, experimentally trac-
table class of neurons. Our in vitro analysis of several pop-
ulations of embryonic mouse sensory neurons populations 
has shown that NRG4 markedly promotes axon growth from 
NGF-dependent neurons early and transiently in their devel-
opment independently of NGF. In vivo analysis showed that 
the cutaneous sensory fibers of NRG4-deficient embryos are 
markedly and significantly shorter than those of wild-type 
littermates. Together with other recently published studies, 
our work adds to the increasing realization that NRG4 is a 
key physiological regulator of neural process growth from a 
variety of classes of neurons throughout the developing ver-
tebrate nervous system.
2 |  RESULTS
2.1 | Axon growth from early NGF-
dependent sensory neurons is promoted by 
NRG4 in vitro independently of NGF
The demonstration that NRG4 promotes axon growth from 
early sympathetic neurons cultured at the stage of development 
when their axons are ramifying in their targets (Pellegrinelli 
et al., 2018), together with the demonstration that NRG4 rescues 
the diminished dendrite phenotype of cortical pyramidal neu-
rons and striatal medium spiny neurons cultured from NRG4-
deficient mice (Paramo et al., 2018, 2019), raised the possibility 
that NRG4 might affect the growth of neural processes of other 
kinds of neurons during development. To test this possibil-
ity, we examined the effect of recombinant NRG4 on three 
well-characterized populations of embryonic mouse sensory 
neurons in vitro. Trigeminal ganglion neurons, which provide 
cutaneous sensory innervation to the face, become dependent 
on target-derived NGF for survival shortly after their periph-
eral axons reach their peripheral targets (Davies et al., 1987). 
The majority of dorsal root ganglion (DRG) neurons likewise 
become dependent on NGF at a similar stage in development 
and the enteroceptive neurons of the nodose ganglion become 
dependent on the related neurotrophin BDNF when their axons 
reach their visceral targets (Vogel & Davies, 1991). In addition 
to promoting and regulating neuronal survival, neurotrophins 
also promote the growth and branching of axons within their 
target tissues (Bibel & Barde, 2001).
We established dissociated low-density cultures of trigem-
inal ganglion, DRG, and nodose ganglion neurons (Figure 1a) 
over a range of stages throughout the initial period of target 
field innervation, beginning at the earliest stages that these 
respective ganglia can be reliably dissected from embryos, 
and compared the effect of NRG4 with that of neurotrophins. 
In marked contrast to neurotrophins, NRG4 had a negligible 
effect on the survival of these neurons at any stage studied 
(not shown). NRG4 did, however, promote axon growth al-
most as effectively as NGF in early trigeminal ganglion and 
DRG neuron cultures. In these experiments, the cultures were 
supplemented with the pancaspase inhibitor Boc_D_FMK to 
prevent apoptosis in the absence of neurotrophins. In E12 
cultures, there was a low level of axon growth in the absence 
of factors, as previously reported (Buchman & Davies, 1993). 
However, in E14 and later cultures neurotrophin-independent 
axon growth was negligible (Figure 1). Neurotrophins effec-
tively promoted axon growth from the earliest stages studied 
(NGF in E12 trigeminal and DRG cultures and BDNF in E14 
nodose cultures) and neurotrophin-promoted axon growth 
was sustained throughout the period of development stud-
ied (up to P3). In E12 trigeminal and DRG cultures, NRG4 
significantly promoted axon growth in the absence of neu-
rotrophins (Figure 1b). By E14, NRG4 was almost as effec-
tive as NGF in promoting axon growth from trigeminal and 
DRG neurons (83% and 78%, respectively) (Figure 1c). This 
marked axon growth-promoting effect of NRG4 was, how-
ever, restricted to early developmental stages. NRG4 had no 
significant effect on axon growth in E16 and older cultures 
(Figure 1d-f). This axon growth-promoting effect of NRG4 
was only observed in the two populations of NGF-dependent 
sensory neurons studied, it had no significant effect on axon 
growth from nodose neurons at any age (Figure 1c-f). To de-
termine the range of NRG4 concentrations over which NRG4 
exerts its early axon growth-promoting action, DRG neurons 
were cultured with different concentrations of NRG4. NRG4 
significantly enhanced axon growth at concentrations be-
tween 10 and 1,000 ng/ml (Figure 1g). This was similar to 
the NRG4 dose-response reported for sympathetic neurons 
(Pellegrinelli et al., 2018). Representative examples of neu-
rons grown in the absence of factors, with NRG4, or with 
neurotrophins are shown in Figure 1h-j.
2.2 | The early maxillary territory has 
greatly diminished innervation in embryos 
lacking NRG4
To ascertain whether the effects of NRG4 on early sensory 
axon growth in vitro are physiologically relevant in vivo we 
used immunolabeling-enabled three-dimensional imaging of 
solvent-cleared organs (iDISCO) (Renier et al., 2014) to visu-
alize the disposition of nerve fibers in peripheral tissues at the 
early stage of development when sensory neurons are respon-
sive to NRG4 in vitro. We focused on the maxillary territory of 
the trigeminal ganglion, which is the most densely innervated 
cutaneous target field of the mouse. The disposition of trigemi-
nal ganglion sensory fibers, which are the first to reach this 
tissue and are the only kind of nerve fibers present in this tissue 
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at this early stage of development, were compared in Nrg4−/− 
and Nrg4+/+ embryos. Axons were labeled using an antibody 
against the neuron-specific marker βIII-tubulin. Nrg4−/− and 
Nrg4+/+ embryos were studied at E12, which is a day after the 
earliest trigeminal axons reach the maxillary cutaneous tissue 
(Davies & Lumsden, 1984) and is before innervation becomes 
increasingly too complex to accurately quantify using this 
method. The representative images illustrated in Figure  2a, 
F I G U R E  1  NRG4 enhances axon growth from early trigeminal and DRG neurons but not nodose neurons. (a) Schematic representation of 
an E12 mouse embryo illustrating location of ganglia used in this study. (b-f) Length of axons growing from low-density dissociated DRG, and 
trigeminal and nodose neurons at E12, E14, E16, P0, and P3 after 24 hr in culture with either no factors (clear bars), 500 ng/ml NRG4, 10 ng/ml 
NGF, or 10 ng/ml BDNF. (g) Length of axons growing from E14 DRG neurons cultured for 24 hr with different concentrations of NRG4. (h–j) 
Representative images of DRG (h), trigeminal (i), and nodose (j) neurons cultured in the absence of factors, with 500 ng/ml NRG4 or with 10 ng/
ml NGF/BDNF, stained with calcein-AM. Scale bar, 100 μm. All cultures received 25 μM Boc-D-FMK. Mean ± SEM of data of >50 neurons per 
condition obtained from three separate experiments. Statistical comparisons with the no factor condition **p < .01, ***p < .001, one-way ANOVA 
with Bonferroni correction
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enlarged in Figure 2b, show that the area into which sensory 
axons splay out was very much smaller in Nrg4−/− embryos 
compared with Nrg4+/+ embryos. Blind quantification of the 
longest nerve fibers in the maxillary processes of multiple 
Nrg4−/− and Nrg4+/+ embryos revealed a highly significant 
18% reduction length in Nrg4−/− embryos compared with 
Nrg4+/+ embryos (Figure  2c). Blind quantification of βIII-
tubulin immunofluorescence in a standard maxillary target 
field area in multiple Nrg4−/− and Nrg4+/+ embryos revealed 
a highly significant 40% reduction in Nrg4−/− embryos com-
pared with Nrg4+/+ embryos (Figure 2d). While there was a 
clear reduction in the extent to which early trigeminal gan-
glion fibers grow and splay out within the maxillary process 
of Nrg4−/− embryos, there was no evidence of any axon guid-
ance defects in these embryos. The arrangement of trigemi-
nal ganglion fibers was entirely normal within the maxillary 
process of Nrg4−/− embryos, they just had not grown as far as 
in Nrg4+/+ embryos. This suggests that NRG4 makes a signifi-
cant contribution to promoting the early growth of peripheral 
cutaneous axons but does not influence the direction in which 
they grow.
2.3 | Diminished length of spinal nerves in 
embryos lacking NRG4
To examine whether the growth of early DRG sensory 
axons is affected in vivo in the absence of NRG4, we ex-
amined the lengths of intercostal nerves and size of the 
brachial plexus in E12 Nrg4−/− and Nrg4+/+ embryos. The 
representative iDISCO images illustrated in Figure 2e, en-
larged in Figure 2f, suggest that the intercostal nerves are 
shorter and brachial plexus is smaller in Nrg4−/− embryos 
compared with Nrg4+/+ embryos. Estimation of these ap-
parent differences were made by measuring the lengths of 
T2–T8 intercostal nerves and quantifying the level of βIII-
tubulin immunofluorescence in a standard area centered 
on the brachial plexus. Analysis of multiple embryos car-
ried out blind revealed a highly significant 20% reduction 
in intercostal nerve length (Figure 2g) and 35% reduction 
in plexus immunofluorescence (Figure 2h) in Nrg4−/− em-
bryos compared with Nrg4+/+ embryos. While our imag-
ing method does not distinguish between sensory and motor 
fibers, which are also present in early intercostal nerves and 
the brachial plexus, our observations are consistent with a 
reduction in early nerve fiber growth in vivo in the absence 
of NRG4. As with maxillary sensory fibers, there was no 
sign of any aberrant fibers in either the early intercostal 
nerves or brachial plexus of Nrg4−/− embryos, suggesting 
no guidance defect in these embryos. This suggests that 
NRG4 makes a significant contribution to promoting the 
early growth of peripheral DRG axons but does not influ-
ence the direction in which they grow.
2.4 | NRG4 activates ErbB4 in 
DRG neurons
The principal receptor for NRG4 is the ErbB4 tyrosine kinase. 
To determine whether NRG4 activates ErbB4 in DRG neu-
rons, dissociated cultures of E12 DRG neurons were treated 
with NRG4 for intervals up to 60 min before the cultures were 
lysed and the level of phospho-ErbB4 determined by Western 
blotting. Controls were either untreated or were treated with 
NGF. The levels of total ErbB4, total ErbB3 and phospho-
ErbB3 were also assessed on the Western blots of lysates, and 
βIII-tubulin was used as a loading standard. A representa-
tive set of Western blots from a single experiment is shown 
in Figure 3a and the densitometry for the levels of phospho-
ErbB4 in multiple experiments are shown in Figure 3b. Total 
ErbB4 and total ErbB3 were detected in these cultures, but 
their levels remained similar under all experimental condi-
tions. Phospho-ErbB3 was undetectable in any experimental 
condition. Similar low levels of phospho-ErbB4 were detect-
able in untreated cultures and in NGF-treated cultures. The 
low level of phospho-ErbB4 was unchanged by NRG4 treat-
ment for up to 30 min, but between 30 and 45 min there was 
a marked, highly significant >2-fold increase in the level of 
phospho-ErbB4 which was sustained for at least an hour after 
NRG4 stimulation. These studies show that NRG4 specifically 
activates ErbB4 in DRG neurons shortly after stimulation.
2.5 | Expression of Nrg4 and ErbB4 mRNAs 
in DRG and their targets during development
To provide an indication of the sites of NRG4 and ErbB4 
synthesis in developing DRG and their peripheral targets, we 
used qPCR to measure the levels of Nrg4 and ErbB4 mRNAs 
relative to housekeeping mRNAs in dissected DRG and cir-
cumscribed components of their cutaneous targets. Consistent 
with the loss of responsiveness of DRG to NRG4 after E14, 
there was a continuous decline in the relative level of ErbB4 
mRNA in DRG with age, with the greatest decrease occur-
ring between E14 and E16 (Figure  4a). Nrg4 mRNA was 
detectable in the DRG and forelimb bud at all ages studied 
(Figure 4b,c). However, at E12, when the response of DRG 
to NRG4 is maximal, the relative level of ErbB4 mRNA in 
DRG was eightfold greater than that of Nrg4 mRNA in DRG 
(Figure 4d). In contrast, the relative level of Nrg4 mRNA in 
forelimb and hindlimb buds was much greater than that of 
ErbB4 mRNA in limb buds (13- and 22-fold, respectively) 
(Figure 4d). While it is conceivable that Nrg4 mRNA might 
be synthesized by blood vessels or other intermediate targets, 
these findings, along with the lack of any guidance defects 
in Nrg4−/−- deficient embryos, are consistent with the idea 
that NRG4 is predominantly, if not exclusively, a cutaneous 
target-derived factor for early DRG neurons.
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3 |  DISCUSSION
We have shown that NRG4 is a key physiologically relevant 
regulator of axon growth from a major subset of sensory 
neurons in embryonic development. In culture, NRG4 en-
hances axon growth from dissociated trigeminal ganglion 
and DRG neurons at the stage of development when their 
axons are beginning to innervate peripheral targets. In the 
F I G U R E  4  Expression of Nrg4 and 
ErbB4 mRNAs in DRG and limb buds. (a, 
b) Graphs showing the relative levels of 
ErbB4 mRNA (a) and Nrg4 mRNA (b) in 
DRG of different ages. (c) Graph showing 
the relative levels of Nrg4 mRNA in the 
forelimb bud of different ages. (d) Bar chart 
of the relative levels of Nrg4 mRNA and 
ErbB4 mRNA in the DRG, forelimb bud 
and hindlimb bud at E12. The levels of Nrg4 
and ErbB4 mRNAs are expressed relative to 
the geometric mean of reference mRNAs for 
glyceraldehyde phosphate dehydrogenase, 
succinate dehydrogenase, and hypoxanthine 
phosphoribosyltransferase-1. The data 
are normalized to 1.0 for the highest level 
of expression of either Nrg4 mRNA or 
ErbB4 mRNA (mean ± SEM of 4 separate 
measurements for each data point)
F I G U R E  3  NRG4 activates ErbB4 in cultured DRG neurons. (a) Representative Western blots probed for phospho-ErbB4, total ErbB4, 
phospho-ErbB3, total ErbB3, and β-III tubulin of lysates of E12 DRG neurons grown for 12 hr with 25 μM Boc-D-FMK and stimulated with either 
500 ng/ml NRG4 for the indicated times or 10 ng/ml NGF for 30 min. (b) Densitometry of phospho-ErbB4 bands from three separate experiments. 
Mean ± SEM of data from three experiments, **p < .01, statistical comparison with unstimulated cultures, ANOVA
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case of trigeminal ganglion neurons, these peripheral targets 
are almost exclusively cutaneous. Furthermore, the great ma-
jority of trigeminal ganglion neurons respond to NGF and 
become dependent on NGF for survival shortly after they 
start innervating their targets (Davies et  al.,  1987). NRG4 
promotes axon growth entirely independently of NGF and 
is almost as efficacious as NGF in promoting axon growth 
during the earliest stages of target field innervation. In con-
trast to NGF, however, the axon growth-promoting action of 
NRG4 is not sustained throughout development. Whereas 
NGF continues to promote axon growth and branching into 
late postnatal development, the effect of NRG4 is transient. 
Trigeminal ganglion and DRG neurons lose responsiveness 
to NRG4 just a few days after their axons encounter their 
targets. Like NGF, however, NRG4 is selective for particular 
kinds of sensory neurons. While we have not explored this 
extensively, it is clear that some populations of embryonic 
sensory neurons are completely unresponsive to NRG4. For 
example, we have shown that the enteroceptive neurons of 
the embryonic nodose ganglion, which respond to the NGF-
related neurotrophin BDNF, but not NGF, show no response 
to NRG4. Whether NRG4 responsiveness is a feature of all 
NGF-responsive sensory neurons or just a subset of these is 
an issue that may be clarified in future work.
The most marked difference between NGF and NRG4 re-
lates to neuronal survival. Whereas NGF sustains the survival 
of the majority of trigeminal ganglion and DRG neurons shortly 
after they begin innervating their targets and is indeed the cru-
cial regulator of the size of these populations of neurons in vivo 
(Crowley et al., 1994), NRG4 has no discernable direct influ-
ence on the survival of cultured neurons. A similar selective 
effect on early axon growth but not survival has recently been 
described for the cytokine CD40L. Here CD40L promotes axon 
growth from embryonic DRG independently of neurotrophins 
over the same early period of development as NRG4. Analysis 
of the site of expression of Cd40l mRNA suggests that CD40L, 
like NRG4, is target-derived. In addition, some CD40L is also 
synthesized by the neurons themselves and there is evidence 
that autocrine CD40L makes a minor contribution to axonal 
growth (Howard et al., 2019). Importantly, as in embryos lack-
ing NRG4, there is an in vivo nerve fiber phenotype in embryos 
lacking CD40, the CD40L receptor. The intercostal nerves are 
significantly shorter and there is a significant reduction in limb 
plexus βIII-tubulin immunofluorescence in Cd40−/− embryos 
compared with wild-type littermates (Howard et al., 2019).
The in vivo sensory fiber phenotype observed in NRG4-
deficient embryos demonstrates the physiological relevance 
of our in vitro observations of the effects of NRG4 on early 
sensory axon growth. In addition to the significant reductions 
in intercostal nerve length and brachial plexus size in Nrg4−/− 
embryos, there are prominent changes in the maxillary target 
field of the trigeminal ganglion of Nrg4−/− embryos. There is 
a marked reduction in βIII-tubulin immunofluorescence and 
the trigeminal fibers are shorter and splay out less into the 
maxillary target field compared with wild-type littermates. 
The very early effect of NRG4 on sensory axon growth both 
in vitro and in vivo raises the possibility that NRG4 plays 
a role in guiding sensory axons to their targets, as has been 
demonstrated for specific target-derived sensory axon attrac-
tants (Lumsden & Davies, 1983, 1986). However, this seems 
unlikely because the gross anatomy of sensory fibers in early 
Nrg4−/− embryos appears normal compared with Nrg4+/+ 
littermates. It, therefore, appears that the principle role of 
NRG4 in the developing sensory nervous system is to ac-
celerate the growth of certain sensory axons to their targets 
without influencing the direction in which they grow.
So what purpose does the early transient enhancement of 
axon growth by NRG4 and CD40L serve? Perhaps the early 
effects of NRG4 and CD40L on sensory axon growth are nec-
essary steps for optimizing termination of sensory fibers in 
their targets to ensure optimal function. Our in vivo analyses 
were performed at E12, when sensory neurons are responsive to 
NRG4 in vitro and differences in innervation between genotypes 
can be accurately measured. Since neither the Nrg4−/− nor the 
Cd40−/− genotype is an embryonic lethal, future in vivo analy-
ses in postnatal mice and functional tests in adults may reveal 
specific sensory deficits associated with specific histological 
phenotypes. Alternatively, the early growth response of sensory 
axons to NRG4 and CD40L could be important elements to en-
sure the correct timing of trophic interactions between neurons 
and their targets. It is known that the onset of neurotrophin de-
pendency in the PNS is coordinated with the commencement of 
target field innervation largely by independent developmental 
programs in the neurons and targets that switch on neurotro-
phin responsiveness and initiate neurotrophin expression, re-
spectively (Davies et  al.,  1987; Rohrer et  al.,  1988; Vogel & 
Davies, 1991). In addition, interaction between arriving axons 
and target fields makes a minor contribution to coordinating 
timing (Wyatt et al., 2011). One would predict that neurons that 
become neurotrophin-dependent before their axons reach the 
source of neurotrophins in the target field may die prematurely. 
For this reason, it will be important in future work to assess the 
neuronal complement of the trigeminal ganglion and DRG in 
postnatal Nrg4−/− and Nrg4+/+ mice.
In summary, we have shown that NRG4 is a physiolog-
ical regulator of the growth of a major subset of sensory 
axons during embryonic development. This work expands 
the role of NRG4 within the nervous system beyond regulat-
ing the growth and branching of sympathetic axons, cortical 
pyramidal neuron dendrites and medium spiny neuron den-
drites (Paramo et al., 2018, 2019; Pellegrinelli et al., 2018). 
However, in contrast to these earlier studies, where NRG4 
influences neural process growth over an extended period of 
late development, the effect of NRG4 on sensory neurons in 
our study is restricted to a very narrow and early develop-
mental window. This illustrates the need for investigating the 
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potential effects of NRG4 on other populations over a broad 
range of ages. Our work also emphasizes the need to investi-
gate the potential participation of NRG4 in neural pathology.
4 |  MATERIALS AND METHODS
4.1 | Animals
This study was conducted on tissues obtained from CD1 wild-
type mice (Mus musculus) and Nrg4 null mutant mice that were 
purchased from the Mutant Mouse Resource Centre, UC Davis 
(California, USA). The Nrg4 locus in these mice was disrupted 
by retroviral insertion of a gene trap between exons 1 and 2. 
The mice were backcrossed from a C57/BL6 background into 
a CD1 background. Nrg4± mice were crossed to generate 
Nrg4+/+ and Nrg4−/− littermates. The mice were housed in a 
12 hr light-dark cycle with access to food and water ad libi-
tum. Breeding was approved by the Cardiff University Ethical 
Review Board and was performed within the guidelines of the 
Home Office Animals (Scientific Procedures) Act, 1986.
4.2 | Neuron culture
Dorsal root ganglia (DRG), trigeminal, and nodose ganglia 
were dissected from staged embryos or postnatal mice and 
were trypsinized, and triturated to generate a suspension of 
cells that were plated at very low density (~500 neurons per 
dish) in poly-ornithine/laminin-coated 35 mm or 4-well tis-
sue culture dishes (Greiner, Germany) in serum-free Hams 
F14 medium (Davies et al., 1993) supplemented with 0.25% 
Albumax I (Life Technologies, UK).
Analysis of axon length was carried out by labeling the 
neurons at the end of the experiment with the fluorescent vital 
dye calcein-AM (Life Technologies, UK). For every condi-
tion in each experiment, images of at least 50 neurons were 
digitally acquired by fluorescence microscopy and analyzed 
to obtain total neurite length (Gutierrez & Davies,  2007). 
Statistical analyses were performed using a one-way ANOVA 
with Bonferroni–Holm post hoc test. Pair-wise comparisons 
were made using Student's t-test. NGF and BDNF were ob-
tained from R&D Systems (Minneapolis, MN, USA) and 
NRG4 was obtained from Thermo Fisher Scientific. The 
culture medium was supplemented with the caspase inhibitor 
Boc-D-FMK (Calbiochem, UK) to prevent neuronal apopto-
sis in the absence of neurotrophins.
4.3 | Western blotting
Western blots were carried out using lysates from dis-
sected DRG cultures. Neurons were plated at high density in 
polyornithine/laminin-coated 96-well plates (5,000 neurons 
per well). The neurons were incubated overnight in medium 
containing 25  µM  Boc-D-FMK (Calbiochem, UK) before 
treating the neurons with either 10 ng/ml NGF or 500 ng/ml 
NRG4. After treatment, the cells were lysed in RIPA buffer 
and insoluble debris was removed by centrifugation. Samples 
were transferred to polyvinylidene difluoride membranes 
using the Bio-Rad TransBlot (Bio-Rad, CA, USA). The mem-
branes were blocked with 5% BSA in phosphate-buffered sa-
line containing 0.1% TWEEN 20. The membranes were then 
incubated with either anti-phospho-ErbB3 antibody (1:1,000, 
ab4791, Cell Signaling Technologies), anti-total ErbB3 anti-
body (1:1,000, ab4754, Cell Signaling Technologies), anti-
phospho-ErbB4 antibody (1:1,000, ab4757, Cell Signaling 
Technologies), anti-total ErbB4 antibody (1:1,000, ab4795, 
Cell Signaling Technologies), or anti-β-III tubulin antibody 
(1:10,000, MAB1195, R&D, MN, USA), which were detected 
using a peroxidase-linked secondary antibody (Promega, WI, 
USA) and the ImmunoCruz™ Western Blotting Luminol 
Reagent (Santa Cruz, CA, USA). Densitometry was carried 
out using Image Studio Lite (Li-Cor Biosciences).
4.4 | Quantitative PCR
The levels of Nrg4 mRNA and ErbB4 mRNA were quantified 
by RT-qPCR relative to a geometric mean of mRNAs for the 
house keeping enzymes glyceraldehyde phosphate dehydro-
genase (Gapdh), succinate dehydrogenase (Sdha), and hypox-
anthine phosphoribosyltransferase-1 (Hprt1). Total RNA was 
extracted from dissected tissues with the RNeasy Mini Lipid 
extraction kit (Qiagen, Crawely, UK). Five microliters of 
total RNA was reverse-transcribed, for 1 hr at 45°C, using the 
AffinityScript kit (Agilent, Berkshire, UK) in a 25 µl reaction 
according to the manufacturer's instructions. Two microliters of 
cDNA was amplified in a 20 µl reaction volume using Brilliant 
III ultrafast qPCR master mix reagents (Agilent Technologies). 
PCR products were detected using dual-labeled (FAM/BHQ1) 
hybridization probes specific to each of the cDNAs (MWG/
Eurofins, Ebersberg, Germany). The PCR primers were: Nrg4 
forward: 5′-GAG ACA AAC AAT ACC AGA AC-3′ and re-
verse: 5′-GGA CTG CCA TAG AAA TGA-3′; ErbB4 forward: 
5′-GGC AAT ATC TAC ATC ACT G-3′ and reverse: 5′-CCA 
ACA ACC ATC ATT TGA A-3′; Gapdh forward: 5′-GAG 
AAA CCT GCC AAG TAT G-3′ and reverse: 5′-GGA GTT 
GCT GTT GAA GTC-3′; Sdha forward: 5′-GGA ACA CTC 
CAA AAA CAG-3′ and reverse: 5′-CCA CAG CAT CAA 
ATT CAT-3′; Hprt1 forward: 5′-TTA AGC AGT ACA GCC 
CCA AAA TG-3′ and reverse: 5′-AAG TCT GGC CTG TAT 
CCA ACA C-3′. Dual-labeled probes were: Nrg4: 5′-FAM-
CGT CAC AGC CAC AGA GAA CAC-BHQ1-3′; ErbB4: 
5′-FAM-AGC AAC CTG TGT TAT TAC CAT ACC ATT-
BHQ1-3′; Gapdh: 5′-FAM-AGA CAA CCT GGT CCT CAG 
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TGT-BHQ1-3; Sdha: 5′-FAM-CCT GCG GCT TTC ACT 
TCT CT-BHQ1-3, Hrpt1: 5′-FAM-TCG AGA GGT CCT TTT 
CAC CAG CAA G-BHQ1-3′. Forward and reverse primers 
were used at a concentration of 250 nM and dual-labeled probes 
were used at a concentration of 500 nM. PCR was performed 
using the Mx3000P platform (Agilent) using the following 
conditions: 95°C for 3 min followed by 45 cycles of 95°C for 
10  s and 60°C for 35  s. Standard curves were generated for 
each cDNA for every real-time PCR run, using serial threefold 
dilutions of reverse-transcribed adult mouse brain total RNA 
(Zyagen, San Diego, USA). Primer and probe sequences were 
designed using Beacon Designer software (Premier Biosoft, 
Palo Alto, USA).
4.5 | Analysis of DRG peripheral nerve 
fibers in vivo
Analysis of nerve fiber growth in vivo was carried out on 
iDISCO preparations (Renier et  al.,  2014) of E12 Nrg4+/+ 
and Nrg4−/− embryos. Briefly, embryos were fixed in 4% 
paraformaldehyde for 24 hr and serially dehydrated in metha-
nol/phosphate-buffered saline (PBS). The samples were then 
bleached overnight in chilled 5% H2O2 to reduce tissue auto-
fluorescence before being serially rehydrated in methanol/
PBS containing 0.2% Triton X-100. The embryos were incu-
bated in blocking solution (6% donkey serum, 20% DMSO, 
0.2% Triton X-100, and 0.3 M Glycine in PBS) for 72 hr at 
37°C. After washing with PBS containing 0.2% Tween-20 and 
10 mg/ml heparin (PTwH), the embryos were incubated with 
βIII-tubulin antibody (1:300, MAB1195, R&D Systems) in 
PTwH containing 5% DMSO and 3% donkey serum for 72 hr 
at 37°C. Following extensive washing in PTwH, the samples 
were incubated with donkey anti-mouse 546 Alexa Fluor sec-
ondary antibody (1:300, A10036, Life Technologies, Paisley, 
UK) in PTwH plus 3% donkey serum for 72 hr at 37°C. After 
further washing in PTwH, samples were cleared by overnight 
incubation in tetrahydrofuran, followed by dichloromethane 
treatment for 15 min. The samples were placed in dibenzyl 
ether (DBE) until clear and imaged while submerged in DBE 
in 3D-printed slide chambers using a Zeiss LSM710 confocal 
microscope. The Nrg4−/− data are expressed as a percentage 
of the mean of Nrg4+/+ data. Quantification of innervation 
was performed using Fiji—ImageJ by measuring the inten-
sity of βIII-tubulin immunolabeling in a standardized region 
centered on either the forelimb plexus or the trigeminal max-
illary territory and by making nerve fiber measurements. All 
imaging and quantification were performed blind with geno-
types determined after quantification.
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